Tilray Brands, Inc. (SWX:2HQ)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 616.68M +38.7% |
| Revenue (ttm) | 659.94M +3.8% |
| Net Income | -1.03B |
| EPS | -9.71 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 12.97 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 3 |
| Open | 462.80 |
| Previous Close | 462.80 |
| Day's Range | 462.80 - 462.80 |
| 52-Week Range | 462.80 - 462.80 |
| Beta | n/a |
| RSI | n/a |
| Earnings Date | Apr 1, 2026 |
About Tilray Brands
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]
Financial Performance
In fiscal year 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
'GIANT STEP FORWARD': Reclassification of medical cannabis lauded
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.' 00:00 Introduction & Re...
'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana
The Trump administration reclassified medical marijuana as a less dangerous drug on Thursday. FDA-approved and state-licensed medical marijuana was rescheduled from a Schedule I drug to the less stric...
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling Food and Drug Administration-approved and state-licensed medical cannabis products as a...
Cannabis Stocks Soared—Than Sank. Here's What Investors Need to Know.
Marijuana-related investments were flying high this morning. Then they reversed course, and quickly.
Tilray CEO on Possible US Cannabis Reclassification
Tilray CEO Irwin Simon discusses the expected easing of cannabis restrictions in the US, and why despite not currently selling cannabis in the United States the opportunity to do so would be 'tremendo...
Cannabis rescheduling fuels optimism across industry
The U.S. Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of reclassifying the drug as less dangerous in one of the biggest changes t...
Tilray stock price soars as we predicted: now what?
The Tilray stock price has risen in the past few days, a trend that accelerated this week. It jumped to a high of $8, up by over 30% from its lowest level this year.
Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients
BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today unveiled its lineup of headliner products and bold innovation bets for spring a...
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Tilray stock shows early reversal signals as U.S. cannabis rescheduling momentum builds, with a breakout and technical strength pointing toward a potential recovery continuation.
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe cou...
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report
Shares of cannabis giant Tilray Brands Inc (NASDAQ:TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift. Here's what investors need to know.
Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
NEW YORK and LEAMINGTON, Ontario, April 20, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company a...
3 Marijuana Stocks That Could Help You Make A Profit In Cannabis
Marijuana stock investors are still in a position where volatility and speculation control the outcome. Especially with all the laws and regulatory changes that have transformed the cannabis industry....
Here's why the Tilray Brands stock may surge soon despite major risks
Tilray Brands stock price has moved sideways in the past few weeks as momentum in the cannabis industry waned. It was trading at $6.90, down by over 70% from its highest level last year.
Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity Tilray Advances UK Healthcare Pl...
3 Canadian Marijuana Stocks For Better Cannabis Investing 2026
Marijuana stock investors who have been trading and holding over the years know this sector holds potential. Now, potential doesn't put money in your pocket, but progressive and profitable companies t...
Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer
TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY) a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and ...
Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts
BRECKENRIDGE, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), announces the re...
Deep dive: why Tilray stock sell-off despite record revenue makes sense
Tilray Brands (NASDAQ: TLRY) is seeing pressure this morning even after reporting an 11% year on year increase in revenue to a record $207 million for its third financial quarter. The price action may...
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year
International Cannabis Accelerates with 73% Net Revenue Growth and 100% Increase in Cannabis Flower Sales Volume Year-Over-Year
Best Canadian Cannabis Stocks for Potential Breakouts in March 2026
The Canadian cannabis sector continues evolving as global opportunities expand. Many companies are now positioning for U.S. entry. Additionally, federal reform discussions in the United States remain ...
Shock Top Launches High Voltage, Its First-Ever High-ABV Beer
PORTLAND, Ore., March 31, 2026 (GLOBE NEWSWIRE) -- Shock Top , a craft beer icon and brand by Tilray Beverages, known for its bold flavors and unfiltered wheat ales, today announced its first-ever hig...
Top stocks to watch this week: Tilray Brands, Nike, FactSet
The stock market will be on edge this week as investors continue focusing on the ongoing Iran war. This focus comes at a time when the Dow Jones, Nasdaq 100, and S&P 500 indices have plunged from thei...